Materias dentro de su búsqueda.
Mostrando 174,281 - 174,300 Resultados de 174,586 Para Buscar '"'39"', tiempo de consulta: 1.40s Limitar resultados
  1. 174281
    “…-The mean pituitary height for patients with IGF z-score < -2 is 3.9 mm, 4 mm for z-score ≥- 2 to ≤ -1 and 4.3 mm for z-score > -1-The mean pituitary height for patients with peak GH < 5 is 3.8 mm, 4.2 mm for peak 5-7.99, 4.3 mm for peak 8-9.99 and 4.4 mm for peak > 10. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SAT-LB19 Is There a Need to Use Gadolinium Contrast for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?
  2. 174282
    “…At least one adverse reaction within the first 7 days was reported in 76 (23%) of 336 vaccine recipients (33 [39%], 8 μg day 0; 18 [21%], 4 μg days 0 and 14; 15 [18%], 4 μg days 0 and 21; and ten [12%], 4 μg days 0 and 28). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
  3. 174283
    por Agarwal, Anup, Mukherjee, Aparna, Kumar, Gunjan, Chatterjee, Pranab, Bhatnagar, Tarun, Malhotra, Pankaj, Agarwal, Anup, Mukherjee, Aparna, Kumar, Gunjan, Chatterjee, Pranab, Bhatnagar, Tarun, Malhotra, Pankaj, Latha, B, Bundas, Sunita, Kumar, Vivek, Dosi, Ravi, Khambholja, Janak Kumar, de Souza, Rosemarie, Mesipogu, Raja Rao, Srivastava, Saurabh, Dube, Simmi, Chaudhary, Kiran, Subash, S, Anbuselvi, S, Rajendran, V, Sundararajaperumal, A, Balamanikandan, P, Maheswari, R S Uma, Jayanthi, R, Ragunanthanan, S, Bhandari, Sudhir, Singh, Ajeet, Pal, Ashok, Handa, Anjali, Rankawat, Govind, Kargirwar, Ketan, Regi, Joyce, Rathod, Darshana, Pathrose, Edwin, Bhutaka, Nirankar, Patel, Mayur H, Verma, Rahul J, Malukani, Kamal, Patel, Shivani, Thakur, Apurv, Joshi, Satish, Kulkarni, Rashmi, Suthar, Nilay N, Shah, Nehal M, Purohit, Hemang M, Shah, Cherry K, Patel, Monila N, Shah, Saket, Shah, Smit T, Memon, Tehsim, Beriwala, Vishal R, Jashnani, Kusum, Ezzy, Fatema, Agrawal, Simran, Bhadade, Rakesh, Atish, MN, Madke, Tushar, Kavishwar, Vikas, Waghmare, Ramesh, Valvi, Nitin, Chander, B Thrilok, Sekhar, A Vinaya, Maurya, Akhilesh Kumar, Hemanth, K, Nagamani, K, Sudha, K, Chandra, T Ravi, Rao, K Tushara, Vyshnavi, J, Upadhyay, Rashmi, Bahadur, Shalini, Pathak, Rambha, Seth, Shikha, Gupta, Rakesh, Saxena, Rita, Dwivedi, Preksha, Malik, Reeni, Chourasia, Deepti, Lalwani, Jaya, Sharma, UM, Marko, JL, Suri, Amit, Kumar, Vijay, Kaushik, Rajnish, Kodan, Parul, Acharya, Bhabani Prasad, Gaur, Kuldeep Kumar, Gupta, Anubhav, Sachdeva, Prerna, Dogra, Shruti, Jindal, Aikaj, John, M Joseph, Dhanju, Avtar Singh, Khetrepal, Ranjana, Sharma, Neeraj, Kukar, Neetu, Kavita, Divya, Kumar, Rajesh, Mahajan, Rajesh, Singh, Gurpreet, Kaur, Jaspreet, Singh, Raminder Pal, Bassi, Rajni, Parikh, Swapneil, Shrivastav, Om, Shastri, Jayanthi, Desai, Maherra, Udupa, Shreevatsa, Bafna, Varun A, Barge, Vijay, Madane, Rajendra, Yadav, Sheetal, Misra, Sanjeev, Bajpayee, Archana, Garg, M K, Bohra, G K, Nag, Vijaylakshmi, Anne, Puneeth Babu, Nadeem, Mohd, Singh, Pallavi, Niwas, Ram, Khaire, Niranjan Shiwaji, Sharma, Rattiram, Singh, Mini P, Sachdeva, Naresh, Sachdev, Suchet, Hans, Rekha, Suri, Vikas, Yaddanapudi, LN, Lakshmi, PVM, Singh, Neha, Bhushan, Divendu, Kumar, Neeraj, Tambe, Muralidhar, Salvi, Sonali, Kadgi, Nalini, Sangle, Shashikala, Nakate, Leena, Joshi, Samir, Karyakarte, Rajesh, Goyanka, Suraj, Sharma, Nimisha, Verma, Nikhil, Das, Asim, Bahl, Monika, Wadhwa, Nitya, Bhat, Shreepad, Deshmukh, Shweta, Wagh, Vrushali, Kulkarni, Atul, Yardi, Tanvi, Kalgud, Ram S, Reddy, Purushottam, Yevoor, Kavitha, Gajula, Prashanth, Maleyur, Vivek, Medini, S, Mohith, HN, Gurtoo, Anil, Sud, Ritika, Pahuja, Sangeeta, Prakash, Anupam, Gogoi, Parijat, Shukla, Shailja, Reddy, D Himanshu, Chandra, Tulika, Pandey, Saurabh, Maurya, Pradeep, Ali, Wahid, Kumar, Vivek, Upadhyay, Kamlesh, Bhatnagar, Nidhi, Shah, Nilima, Shah, Mamta, Patel, Tarak, Jaiswal, Ram Mohan, Jain, Ashish, Sharma, Shweta, Rijhwani, Puneet, Gupta, Naveen, Patel, Tinkal C, Solu, Mahesh G, Patel, Jitendra, Shah, Yash R, Jarag, Mayur, Godbole, Varsha, Shah, Meenakshi, Raj, Rikin, Nagori, Irfan, Jha, Pramod R, Shah, Arti D, Yeeli, Gowtham, Jain, Archit, Gill, Rooppreet Kaur, Babu, KV Sreedhar, Babu, B Suresh, Mohan, Alladi, Vengamma, B, Sekhar, K Chandra, Damam, Srinivasulu, Narsimhulu, K, Aparna, C, Baleswari, G, Reddy, K Ravindranath, Chandrasekhar, P, Panjwani, Sunil Jodharam, Shah, Pragnesh H, Barvaliya, Manish, Desai, Kairavi, Akholkar, Pankaj J, Baldi, Milind, Yadav, Ashok, Gupta, Manoj, Rawat, Nitin, Chawda, Dilip, Natarajan, M, Sintha, M, Kumar, David Pradeep, Rabbani, Fathhur, Khadke, Vrushali Khirid, Patki, Dattatray, Marathe, Sonali, D’Souza, Clyde, Tadha, Vipul, Arora, Satyam, Gupta, Devendra Kumar, Dua, Seema, Chauhan, Nitu, Chahar, Ajeet Singh, Mammen, Joy John, Kumar, Snehil, Daniel, Dolly, Singh, Ravindraa, Dhat, Venkatesh, Agarwal, Yogesh, Arora, Sohini, Pathak, Ashish, Purohit, Manju, Sharma, Ashish, Sharma, Jayashree, Madkaikar, Manisha, Joshi, Kavita, Yadav, Reetika Malik, Bhagwat, Swarupa, Karnik, Niteen D, Gokhale, Yojana A, Naik, Leena, Margam, Sangita, Das, Santasabuj, Turuk, Alka, Kumar, V Saravana, Kanagasabai, K, Sabarinathan, R, Deshpande, Gururaj, Sharma, Sharda, Gunjikar, Rashmi, Shete, Anita, Phagiwala, Darpan, Patil, Chetan, Shingade, Snehal, Jarande, Kajal, Kaushal, Himanshu, Yadav, Pragya, Sapkal, Gajanan, Abraham, Priya
    Publicado 2020
    “…DESIGN: Open label, parallel arm, phase II, multicentre, randomised controlled trial. SETTING: 39 public and private hospitals across India. PARTICIPANTS: 464 adults (≥18 years) admitted to hospital (screened 22 April to 14 July 2020) with confirmed moderate covid-19 (partial pressure of oxygen in arterial blood/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio between 200 mm Hg and 300 mm Hg or a respiratory rate of more than 24/min with oxygen saturation 93% or less on room air): 235 were assigned to convalescent plasma with best standard of care (intervention arm) and 229 to best standard of care only (control arm). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
  4. 174284
    por Nogueira, Raul G., Abdalkader, Mohamad, Qureshi, Muhammed M., Frankel, Michael R., Mansour, Ossama Yassin, Yamagami, Hiroshi, Qiu, Zhongming, Farhoudi, Mehdi, Siegler, James E., Yaghi, Shadi, Raz, Eytan, Sakai, Nobuyuki, Ohara, Nobuyuki, Piotin, Michel, Mechtouff, Laura, Eker, Omer, Chalumeau, Vanessa, Kleinig, Timothy J., Pop, Raoul, Liu, Jianmin, Winters, Hugh S., Shang, Xianjin, Vasquez, Alejandro Rodriguez, Blasco, Jordi, Arenillas, Juan F., Martinez-Galdamez, Mario, Brehm, Alex, Psychogios, Marios-Nikos, Lylyk, Pedro, Haussen, Diogo C., Al-Bayati, Alhamza R., Mohammaden, Mahmoud H., Fonseca, Luísa, Luís Silva, M, Montalverne, Francisco, Renieri, Leonardo, Mangiafico, Salvatore, Fischer, Urs, Gralla, Jan, Frei, ,Donald, Chugh, Chandril, Mehta, Brijesh P., Nagel, Simon, Mohlenbruch, Markus, Ortega-Gutierrez, Santiago, Farooqui, Mudassir, Hassan, Ameer E., Taylor, Allan, Lapergue, Bertrand, Consoli, Arturo, Campbell, Bruce CV, Sharma, Malveeka, Walker, Melanie, Van Horn, Noel, Fiehler, Jens, Nguyen, Huy Thang, Nguyen, Quoc T., Watanabe, Daisuke, Zhang, Hao, Le, Huynh V., Nguyen, Viet Q., Shah, Ruchir, Devlin, Thomas, Khandelwal, Priyank, Linfante, Italo, Izzath, Wazim, Lavados, Pablo M., Olavarría, Veronica V., Sampaio Silva, Gisele, de Carvalho Sousa, Anna Verena, Kirmani, Jawad, Bendszus, Martin, Amano, Tatsuo, Yamamoto, Ryoo, Doijiri, Ryosuke, Tokuda, Naoki, Yamada, Takehiro, Terasaki, Tadashi, Yazawa, Yukako, Morris, Jane G., Griffin, Emma, Thornton, John, Lavoie, Pascale, Matouk, Charles, Hill, Michael D., Demchuk, Andrew M., Killer-Oberpfalzer, Monika, Nahab, Fadi, Altschul, Dorothea, Ramos-Pachón, Anna, Pérez de la Ossa, Natalia, Kikano, Raghid, Boisseau, William, Walker, Gregory, Cordina, Steve M., Puri, Ajit, Luisa Kuhn, Anna, Gandhi, Dheeraj, Ramakrishnan, Pankajavalli, Novakovic-White, Roberta, Chebl, Alex, Kargiotis, Odysseas, Czap, Alexandra, Zha, Alicia, Masoud, Hesham E., Lopez, Carlos, Ozretic, David, Al-Mufti, Fawaz, Zie, Wenjie, Duan, Zhenhui, Yuan, Zhengzhou, Huang, Wenguo, Hao, Yonggang, Luo, Jun, Kalousek, Vladimir, Bourcier, Romain, Guile, Romain, Hetts, Steven, Al-Jehani, Hosam M., AlHazzani, Adel, Sadeghi-Hokmabadi, Elyar, Teleb, Mohamed, Payne, Jeremy, Lee, Jin Soo, Hong, Ji Man, Sohn, Sung-Il, Hwang, Yang-ha, Shin, Dong Hoon, Roh, Hong Gee, Edgell, Randy, Khatri, Rakesh, Smith, Ainsley, Malik, Amer, Liebeskind, David, Herial, Nabeel, Jabbour, Pascal, Magalhaes, Pedro, Ozdemir, Atilla Ozcan, Aykac, Ozlem, Uwatoko, Takeshi, Dembo, Tomohisa, Shimizu, Hisao, Sugiura, Yuri, Miyashita, Fumio, Fukuda, Hiroki, Miyake, Kosuke, Shimbo, Junsuke, Sugimura, Yusuke, Beer-Furlan, Andre, Joshi, Krishna, Catanese, Luciana, Abud, Daniel Giansante, Neto, Octavio Giansante, Mehrpour, Masoud, Al Hashmi, Amal, Saqqur, Mahar, Mostafa, Abdulrahman, Fifi, Johanna T., Hussain, Syed, John, Seby, Gupta, Rishi, Sivan-Hoffmann, Rotem, Reznik, Anna, Sani, Achmad Fidaus, Geyik, Serdar, Akıl, Eşref, Churojana, Anchalee, Ghoreishi, Abdoreza, Saadatnia, Mohammad, Sharifipour, Ehsan, Ma, Alice, Faulder, Ken, Wu, Teddy, Leung, Lester, Malek, Adel, Voetsch, Barbara, Wakhloo, Ajay, Rivera, Rodrigo, Barrientos Iman, Danny Moises, Pikula, Aleksandra, Lioutas, Vasileios-Arsenios, Thomalla, Gotz, Birnbaum, Lee, Machi, Paolo, Bernava, Gianmarco, McDermott, Mollie, Kleindorfer, Dawn, Wong, Ken, Patterson, Mary S., Fiorot, Jose Antonio, Huded, Vikram, Mack, William, Tenser, Matthew, Eskey, Clifford, Multani, Sumeet, Kelly, Michael, Janardhan, Vallabh, Cornett, Oriana, Singh, Varsha, Murayama, Yuichi, Mokin, Maxim, Yang, Pengfei, Zhang, Xiaoxi, Yin, Congguo, Han, Hongxing, Peng, Ya, Chen, Wenhuo, Crosa, Roberto, Frudit, Michel Eli, Pandian, Jeyaraj D., Kulkarni, Anirudh, Yagita, Yoshiki, Takenobu, Yohei, Matsumaru, Yuji, Yamada, Satoshi, Kono, Ryuhei, Kanamaru, Takuya, Yamazaki, Hidekazu, Sakaguchi, Manabu, Todo, Kenichi, Yamamoto, Nobuaki, Sonoda, Kazutaka, Yoshida, Tomoko, Hashimoto, Hiroyuki, Nakahara, Ichiro, Cora, Elena, Volders, David, Ducroux, Celina, Shoamanesh, Ashkan, Ospel, Johanna, Kaliaev, Artem, Ahmed, Saima, Rashid, Umair, Rebello, Leticia C., Pereira, Vitor Mendes, Fahed, Robert, Chen, Michael, Sheth, Sunil A, Palaiodimou, Lina, Tsivgoulis, Georgios, Chandra, Ronil, Koyfman, Feliks, Leung, Thomas, Khosravani, Houman, Dharmadhikari, Sushrut, Frisullo, Giovanni, Calabresi, Paolo, Tsiskaridze, Alexander, Lobjanidze, Nino, Grigoryan, Mikayel, Czlonkowska, Anna, de Sousa, Diana Aguiar, Demeestere, Jelle, Liang, Conrad, Sangha, Navdeep, Lutsep, Helmi L., Ayo-Martín, Óscar, Cruz-Culebras, Antonio, Tran, Anh D., Young, Chang Y., Cordonnier, Charlotte, Caparros, Francois, De Lecinana, Maria Alonso, Fuentes, Blanca, Yavagal, Dileep, Jovin, Tudor, Spelle, Laurent, Moret, Jacques, Khatri, Pooja, Zaidat, Osama, Raymond, Jean, Martins, Sheila, Nguyen, Thanh
    Publicado 2021
    “…SARS-CoV-2 infection was noted in 3.9% (784/20,250) of all stroke admissions. CONCLUSION: The COVID-19 pandemic was associated with a global decline in the volume of overall stroke hospitalizations, mechanical thrombectomy procedures, and intracranial hemorrhage admission volumes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global impact of COVID-19 on stroke care
  5. 174285
    “…HCQ probably increases the risk of adverse events compared with placebo (RR 2.39, 95% CI 1.83 to 3.11; 700 participants; 1 trial; moderate‐certainty evidence). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
  6. 174286
    “…Le scanner thoracique retrouvait une atteinte parenchymateuse > 50 % chez 39 (45 %) patients. Les glucocorticoïdes étaient utilisés chez 34 (35 %) patients. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tocilizumab au cours du COVID-19 : le plus tôt serait le mieux ? Une analyse exploratoire de cohorte
  7. 174287
    “…From the phase 1 trial, 3-month post-second-dose GMTs (MNT(50)) were 39·9 (95% CI 32·0–49·9) in the 3μg with Algel-IMDG group, 69·5 (53·7–89·9) in the 6 μg with Algel-IMDG group, 53·3 (40·1–71·0) in the 6 μg with Algel group, and 20·7 (14·5–29·5) in the Algel alone group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
  8. 174288
    “…Five (5%) pts were taking bosutinib, 12 (11%) dasatinib, 39 (36%) imatinib, 17 (16%), nilotinib, 2 (2%) ponatinib, 1 (1%) HQP1315 and 1 pt (1%) was treated with an unknown TKI. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
  9. 174289
    “…In multivariable analysis controlling for age, sex, and BMI, a PF1.2 >500 pmol/L was significantly associated with VTE [adjusted odds ratio (OR) 4.26, 95% CI, 1.12-16.21, P=0.034] and any thrombotic manifestation (adjusted OR 3.85, 95% CI, 1.39-10.65, P=0.010); conversely, synchronously measured D-dimer >2,500 ng/mL was not significantly associated with VTE (OR 5.91, 95% CI, 0.69-50.56, P=0.11) or any thrombotic manifestation (OR 2.47, 95% CI, 0.78-7.78, P=0.12). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
  10. 174290
    por Kremsner, Peter G, Ahuad Guerrero, Rodolfo Andrés, Arana-Arri, Eunate, Aroca Martinez, Gustavo Jose, Bonten, Marc, Chandler, Reynaldo, Corral, Gonzalo, De Block, Eddie Jan Louis, Ecker, Lucie, Gabor, Julian Justin, Garcia Lopez, Carlos Alberto, Gonzales, Lucy, Granados González, María Angélica, Gorini, Nestor, Grobusch, Martin P, Hrabar, Adrian D, Junker, Helga, Kimura, Alan, Lanata, Claudio F, Lehmann, Clara, Leroux-Roels, Isabel, Mann, Philipp, Martinez-Reséndez, Michel Fernando, Ochoa, Theresa J, Poy, Carlos Alberto, Reyes Fentanes, Maria Jose, Rivera Mejia, Luis Maria, Ruiz Herrera, Vida Veronica, Sáez-Llorens, Xavier, Schönborn-Kellenberger, Oliver, Schunk, Mirjam, Sierra Garcia, Alexandra, Vergara, Itziar, Verstraeten, Thomas, Vico, Marisa, Oostvogels, Lidia
    Publicado 2022
    “…FINDINGS: Between Dec 11, 2020, and April 12, 2021, 39 680 participants were enrolled and randomly assigned to receive either CVnCoV (n=19 846) or placebo (n=19 834), of whom 19 783 received at least one dose of CVnCoV and 19 746 received at least one dose of placebo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
  11. 174291
    “…Baseline proportion of NH discharges due to hospitalization was 37% and 39% in the control and decol groups. In the intervention period, proportions were 36% and 33%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    5. The PROTECT Trial: A Cluster Randomized Clinical Trial of Universal Decolonization with Chlorhexidine and Nasal Povidone Iodine Versus Standard of Care for Prevention of Infections and Hospital Readmissions among Nursing Home Residents
  12. 174292
    “…RESULTS: An independent Data Review Committee (DRC) provided an assessment of treatment response for 74 patients enrolled in the FURI study from 22 centers in US, UK and EU treated with ibrexafungerp for mucocutaneous or invasive fungal infections from 2016- 2020. A total of 39 (52.7%) patients had invasive candidiasis, 32 (43.2%) had mucocutaneous candidiasis and 3 (4.5%) patients had invasive aspergillosis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
  13. 174293
    “…GMTs moderately increased following a primary third dose, from 21·8 (95% CI 17·3–27·6) on day 28 after the second dose to 45·8 (35·7–58·9) on day 28 after the third dose in cohort 1a-14d-2m (n=54), and from 38·1 (28·4–51·1) to 49·7 (39·9–61·9) in cohort 2a-28d-2m (n=53). GMTs had decayed to near the positive threshold by 6 months after the third dose: GMT 9·2 (95% CI 7·1–12·0) in cohort 1a-14d-2m and 10·0 (7·3–13·7) in cohort 2a-28d-2m. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
  14. 174294
    “…At median follow up ranging from 31 to 39 months, BR had superior TTNT to DRC (median: not reached and 104 months, p=0.007, figure 1C) and Rit. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global Waldenström's Macroglobulinemia Patient-Derived Data Registry, Whimsical, Highlights Real-World Treatment Outcomes and COVID-19 Data
  15. 174295
    “…The risk of death at 30 days following study entry in patients who had prior COVID-19 infection or who contracted COVID-19 during this period was 13.6%, compared to 3.9% in the overall cohort without COVID-19 infection. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program
  16. 174296
    “…Ten (59%) alloHCT patients were on immunosuppressant therapy at the time of COVID-19 diagnosis. Fifteen (39%) patients were on active treatment for their hematologic malignancy (HM) at the time of COVID-19 diagnosis with a mean of 3 previous lines of treatment (range: 1-6). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
  17. 174297
    por Chun, Yong-Min
    Publicado 2019
    “…Arthroscopic remplissage for humeral defect in anterior shoulder instability: is it needed. in 39th annual meeting of Japan Shoulder Society, Tokyo. 2012. 10. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Remplissage Procedure: When and How?
  18. 174298
    “…The descriptions of all genera in the Ophiostomatales were standardised and refined where this was required and 39 new combinations have been provided for species in the newly emerging genera and one new combination has been provided for Sporothrix. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Generic boundaries in the Ophiostomatales reconsidered and revised
  19. 174299
    “…Stool, 6 studies Xpert Ultra summary sensitivity verified by culture was 56.1% (95% CI 39.1 to 71.7; 200 participants; moderate‐certainty evidence), and specificity was 98.0% (95% CI 93.3 to 99.4; 1232 participants; high certainty‐evidence). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
  20. 174300
    por Adams, Katherine, Rhoads, Jillian P, Surie, Diya, Gaglani, Manjusha, Ginde, Adit A, McNeal, Tresa, Talbot, H Keipp, Casey, Jonathan D, Zepeski, Anne, Shapiro, Nathan I, Gibbs, Kevin W, Files, D Clark, Hager, David N, Frosch, Anne E, Exline, Matthew C, Mohamed, Amira, Johnson, Nicholas J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Lauring, Adam S, Khan, Akram, Busse, Laurence W, Duggal, Abhijit, Wilson, Jennifer G, Chang, Steven Y, Mallow, Christopher, Kwon, Jennie H, Chappell, James D, Halasa, Natasha, Grijalva, Carlos G, Lindsell, Christopher J, Lester, Sandra N, Thornburg, Natalie J, Park, SoHee, McMorrow, Meredith L, Patel, Manish M, Tenforde, Mark W, Self, Wesley H, Ghamande, Shekhar, Calhoun, Nicole, Murthy, Kempapura, Herrick, Judy, McKillop, Amanda, Hoffman, Eric, Zayed, Martha, Smith, Michael, Kozikowski, Lori-Ann, De Souza, Lesley, Ouellette, Scott, Bolstad, Michael, Coviello, Brianna, Ciottone, Robert, Devilla, Arnaldo, Grafals, Ana, Higgins, Conor, Ottanelli, Carlo, Redman, Kimberly, Scaffidi, Douglas, Weingart, Alexander, Lewis, Nathaniel, Mehkri, Omar, Mitchell, Megan, Griffith, Zachary, Brennan, Connery, Ashok, Kiran, Poynter, Bryan, ten Lohuis, Caitlin, Stanley, Nicholas, Zhang, Sophia, Prekker, Matthew, Erickson, Heidi, Hendrickson, Audrey, Caspers, Sean, Tordsen, Walker, Kaus, Olivia, Scharber, Tyler, Lumpkin, Jenna, Smith, Cassie, Marshall, Hunter, Shehu, Arber, Ali, Harith, Rothman, Richard E, Mohamed, Amira, Nair, Rahul, Chen, Jen-Ting (Tina), Karow, Sarah, Robart, Emily, Maldonado, Paulo Nunes, Khan, Maryiam, So, Preston, So, Madison, Schwartz, Elizabeth, Botros, Mena, Hough, Catherine L, Jung, Haeun, Martinez, Jesus, Luong, Andrea, Huynh, Bao, Ibrahim, Habiba, Villanueva-Vargas, Cynthia, Villanueva-Vargas, Juliana, Quadri, Suha, Gordon, Alexandra June, Levitt, Joe, Perez, Cynthia, Visweswaran, Anita, Roque, Jonasel, Qadir, Nida, Frankel, Trevor, Garner, Omai, Chandrasekaran, Sukantha, Douin, David, Jensen, Kelly, Huynh, David, Steinwand, Aimee, Withers, Cori, Mohr, Nicholas, Nassar, Paul, Landers, Shannon, Nielsen, Karin, Briggs, Noble, Fairfield, Cathy, Gershengorn, Hayley, Rivas, Carolina, Monto, Arnold, McSpadden, E J, Truscon, Rachel, Kaniclides, Anne, Thomas, Lara, Bielak, Ramsay, Valvano, Weronika Damek, Fong, Rebecca, Fitzsimmons, William J, Blair, Christopher, Gilbert, Julie, Baker, Leigh, Srinivasan, Vasisht, Crider, Christine D, Steinbock, Kyle A, Paulsen, Thomas C, Anderson, Layla A, Jones, Ian, Womack, Kelsey, Baughman, Adrienne, Kampe, Christy, Johnson, Jakea, Hart, Kim, Rice, Todd, Stubblefield, William B, Zhu, Yuwei, Short, Laura L, Ezzell, Lauren J, Whitsett, Margaret E, McHenry, Rendie E, Hargrave, Samarian J, Blair, Marcia, Luther, Jennifer L, Pulido, Claudia Guevara, Peterson, Bryan P M, LaRose, Mary, Landreth, Leigha, Hicks, Madeline, Parks, Lisa, Babcock, Hilary, Bongu, Jahnavi, McDonald, David, Cass, Candice, Seiler, Sondra, Park, David, Hink, Tiffany, Wallace, Meghan, Burnham, Carey-Ann, Arter, Olivia G
    Publicado 2022
    “…RESULTS: Overall, median age of participants was 64 years (interquartile range 52-75 years), 994 (20.8%) were immunocompromised, 85 (1.8%) were vaccinated with a primary series plus two boosters, 1367 (28.7%) with a primary series plus one booster, and 1875 (39.3%) with a primary series alone, and 1433 (30.1%) were unvaccinated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Herramientas de búsqueda: RSS